RISCPoint announces Q2 of 2024 Promotions
As RISCPoint continues to expand and innovate, we congratulate our recent promotees and look forward to their continued success in supporting RISCPoint, our customers, and our partners:
"We are thrilled to recognize the dedication and hard work of these exceptional employees," said
These promotions come at a pivotal time for RISCPoint as the company continues to experience growth in product development, market expansion, and customer acquisition. The promoted individuals will play a key role in RISCPoint's strategy to innovate new cybersecurity solutions, expand into emerging markets, and enhance customer satisfaction through improved service delivery.
RISCPoint is committed to investing in its employees and providing opportunities for professional development. These promotions reflect the company's belief that nurturing talent from within is essential to achieving long-term success.
About RISCPoint
RISCPoint Advisory Group is an industry leader in providing custom-tailored security and compliance services. Founded with the vision to seamlessly integrate with teams, while utilizing only high-performing professionals with deep technical and operational expertise, RISCPoint has successfully served companies ranging from Fortune 10 to pre-Series A startups.
To learn more, visit riscpoint.com/contact or call (888) 320-1327.
Website: https://www.riscpoint.com/
LinkedIn: https://www.linkedin.com/company/riscpoint/
Careers: https://www.riscpoint.com/careers
View original content to download multimedia:https://www.prnewswire.com/news-releases/riscpoint-announces-q2-of-2024-promotions-302245986.html
SOURCE RISCPoint
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nuix Takes to Sibos 2026 to help Financial Institutions Turn Complex Data into Financial Crime Intelligence
- Amyotrophic Lateral Sclerosis Market Set for Robust Growth Driven by Innovation and Pipeline Advances by 2036 – DelveInsight | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK
- Spinal Cord Injury Market Size, Emerging Therapies, and Forecast Insights Through 2036 – DelveInsight | Nipro Corp, Kringle Pharma, Abbvie, Neuroplast, Kringle Pharma, Neuroplast, Abbvie
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share